Molecular Partners (MOLN) Stock Chart & Stock Price History $3.76 +0.21 (+5.92%) Closing price 08/22/2025 03:53 PM EasternExtended Trading$3.88 +0.12 (+3.06%) As of 08/22/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Molecular Partners Stock Price Performance The Molecular Partners (MOLN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 39.65%, with a year-to-date return of -20.84%. In the past month, the stock has decreased 3.32%, reflecting recent market activity. As of the latest close, Molecular Partners traded at $3.76 with a market cap of $151.83 million and volume of 2,151 shares. Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.44%1 Month Performance-3.32%3 Month Performance-7.25%Year-To-Date Performance-20.84%1 Year Performance-39.65% MOLN Stock Chart for Sunday, August, 24, 2025 MOLN Chart by TradingView Molecular Partners Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$3.55$3.76+5.92%$3.89$3.672,151 shs$151.83 million08/21/2025$3.62$3.55-1.83%$3.55$3.53752 shs$143.35 million08/20/2025$3.60$3.62+0.44%$3.54$3.54279 shs$146.00 million08/19/2025$3.51$3.60+2.56%$3.60$3.48327 shs$145.37 million08/18/2025$3.54$3.51-0.71%$3.54$3.472,611 shs$141.73 million08/15/2025$3.54$3.54-0.03%$3.59$3.472,607 shs$142.74 million08/14/2025$3.68$3.54-3.94%$3.52$3.463,190 shs$142.77 million08/13/2025$3.69$3.68-0.24%$3.68$3.56727 shs$148.64 million08/12/2025$3.67$3.69+0.65%$3.58$3.58250 shs$149.00 million08/11/2025$3.56$3.67+2.95%$3.51$3.47795 shs$148.02 million Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$3.63$3.56-1.77%$3.67$3.671,281 shs$143.78 million08/07/2025$3.55$3.63+2.26%$3.67$3.671,281 shs$146.38 million08/06/2025$3.67$3.55-3.30%$3.48$3.47764 shs$143.15 million08/05/2025$3.73$3.67-1.58%$3.94$3.60381 shs$148.02 million08/04/2025$3.53$3.73+5.52%$3.65$3.65675 shs$150.42 million08/01/2025$3.68$3.53-4.10%$3.53$3.41424 shs$142.54 million07/31/2025$3.77$3.68-2.33%$3.70$3.70270 shs$148.64 million07/30/2025$3.80$3.77-0.79%$3.85$3.651,116 shs$152.17 million07/29/2025$3.88$3.80-2.09%$3.96$3.921,380 shs$153.40 million07/28/2025$4.01$3.88-3.22%$3.95$3.94938 shs$156.67 million07/25/2025$3.89$4.01+3.09%$4.00$3.832,113 shs$161.88 million07/24/2025$3.89$3.89-0.03%$4.00$3.831,976 shs$157.04 million07/23/2025$3.85$3.89+1.17%$3.90$3.90889 shs$150.67 million Related Companies Xencor Stock Chart Palvella Therapeutics Stock Chart Sage Therapeutics Stock Chart Rapport Therapeutics Stock Chart Savara Stock Chart Arvinas Stock Chart Opthea Stock Chart Bicycle Therapeutics Stock Chart Septerna Stock Chart Zevra Therapeutics Stock Chart Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MOLN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access